| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Pauling David | Chief Admin. Ofcr. & GC | C/O SUTRO BIOPHARMA, INC., 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO | /s/ David Pauling | 16 Oct 2025 | 0002063633 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | STRO | Common Stock | Purchase | $9,993 | +12,504 | +21% | $0.7992 | 71,737 | 15 Oct 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The reported total includes 2,500 shares of Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its Employee Stock Purchase Plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c). |